AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Collectively, this systematic investigation revealed that 8-OHD exerts anti-CML effects by downregulating JAK/STAT, PI3K/AKT, MMP, and OXPHOS pathways, and MYC expression.